共 63 条
- [1] Zhang K(2006)Administrative claims analysis of the relationship between warfarin use and risk of hemorrhage including drug-drug and drug-disease interactions J Manag Care Pharm 12 640-648
- [2] Young C(2016)Impact of a guideline for the management of antimicrobial/warfarin interactions in the inpatient setting and across transition of care Ann Pharmacother 50 734-740
- [3] Berger J(2016)Evaluation of a potential interaction between new regimens to treat hepatitis C and warfarin Ann Pharmacother 50 909-917
- [4] Ha NB(2003)Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions Semin Vasc Med 3 221-230
- [5] Yang K(2015)Perioperatively acquired disorders of coagulation Curr Opin Anaesthesiol 28 113-122
- [6] Hanigan S(2001)Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions Clin Pharmacokinet 40 833-868
- [7] DeCarolis DD(2001)Atrial fibrillation after cardiac surgery Ann Intern Med 135 1061-1073
- [8] Westanmo AD(2008)Characteristics of the amiodarone-warfarin interaction during long-term follow-up Am J Health Syst Pharm 65 947-952
- [9] Chen YC(2010)An evaluation of the early pharmacodynamic response after simultaneous initiation of warfarin and amiodarone J Clin Pharmacol 50 693-698
- [10] Boese AL(2001)Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy J Cardiovasc Pharmacol Ther 6 363-367